Clinical Trial

Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research is to understand cancer related fatigue in patients with non-small cell lung cancer (NSCLC), who are being treated with an immune checkpoint inhibitor.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-08-30 -> 2027-01 2026-08-11
minor Completion pushed: 2026-12-30 -> 2027-07 2026-08-11
Trial Details
NCT Number NCT06567704
Lead Sponsor Wake Forest University Health Sciences
Collaborators: Atrium Health Levine Cancer Institute
Conditions Non-small Cell Lung Cancer
Enrollment 20 participants
Start Date 2025-03-26
Primary Completion 2027-01 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-10